Original language | English (US) |
---|---|
Pages (from-to) | S1-S2 |
Journal | American Journal of Cardiology |
Volume | 101 |
Issue number | 11 SUPPL. |
DOIs | |
State | Published - Jun 2 2008 |
Funding
Gregg C. Fonarow, MD , has served as a consultant for Amgen Inc., AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Inc., Merck & Co., Inc., NitroMed, Inc., Otsuka Pharmaceutical Co., Pfizer Inc, sanofi-aventis, Schering-Plough, and Scios, Inc.; has received research/grant support from Amgen Inc., GlaxoSmithKline, Medtronic, Inc., the National Institutes of Health (NIH), Pfizer Inc, and Scios. Inc.; and has received honoraria from Abbott Laboratories, Amgen Inc., AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, King, Inc., Merck & Co., Inc., NitroMed, Inc., Pfizer Inc, sanofi-aventis, Schering-Plough, and Scios, Inc.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine